[Prognostic role of p53 gene polymorphism in risk assessment of anthracycline-induced cardiotoxicity] [0.03%]
p53基因多态性在蒽环类诱导的心脏毒性风险评估中的预后作用
S N Shilov,A T Teplyakov,A A Popova et al.
S N Shilov et al.
Aims: To study the prognostic significance of polymorphism of the p53 gene (polymorphism Arg72Pro exon 4, rs1042522) on the development of cardiotoxic remodeling of the left ventricle and heart failure. ...
[Non-pharmaceutical treatment of dyslipidemia: review of current methods of diet and nutraceuticals] [0.03%]
[Dys脂血症的非药物治疗：饮食和营养素的综述研究]
N V Polenova,S D Kosura,Yu R Varaeva et al.
N V Polenova et al.
The role of nutrition in the development and progression of atherosclerosis is well known. The correction of diet in patients with dyslipidemia is important as an independent intervention (in the group of patients with low and, partially, m...
A G Obrezan,D Z Baranov
A G Obrezan
Chronic heart failure is the cause of hospitalization of every fifth cardiological patient. Number of patients with heart failure symptoms that have preserved or intermediate left ventricle ejection fraction increases, i.e. grows portion of...
A G Obrezan,D Z Baranov
A G Obrezan
Chronic heart failure is the cause of hospitalization of every fifth cardiological patient. Number of patients with heart failure symptoms that have preserved or intermediate left ventricle ejection fraction increases, i.e. grows portion of...
A V Alessenko,D A Zateyshchikov,A Т Lebedev et al.
A V Alessenko et al.
Lipid metabolism disorders are the most significant risk factor of development of cardiovascular diseases (CVD). In the process of diagnosing ischemic heart disease and other cardiovascular pathologies, levels of total cholesterol, low- and...
A V Alessenko,D A Zateyshchikov,A Т Lebedev et al.
A V Alessenko et al.
Lipid metabolism disorders are the most significant risk factor of development of cardiovascular diseases (CVD). In the process of diagnosing ischemic heart disease and other cardiovascular pathologies, levels of total cholesterol, low- and...
[Target Levels of Arterial Pressure in Patients with Arterial Hypertension and Stroke] [0.03%]
[高血压和卒中患者的血压控制目标]
E A Lopina,A G Dushina,R A Libis
E A Lopina
Number of patients with arterial hypertension and stroke steadily grows. "Target" levels of arterial pressure are not established in patients after stroke. In this review, we present results of clinical trials and data of meta-analyses on t...
[Target Levels of Arterial Pressure in Patients with Arterial Hypertension and Stroke] [0.03%]
[高血压和卒中患者的血压控制目标]
E A Lopina,A G Dushina,R A Libis
E A Lopina
Number of patients with arterial hypertension and stroke steadily grows. "Target" levels of arterial pressure are not established in patients after stroke. In this review, we present results of clinical trials and data of meta-analyses on t...
E V Vyshlov,V V Ryabov
E V Vyshlov
This review article contains presentation of modern diagnostic criteria and prognostic scales for cardiogenic shock in patients with myocardial infarction as well as analysis of current clinical guidelines. Main results of clinical trials u...
E V Vyshlov,V V Ryabov
E V Vyshlov
This review article contains presentation of modern diagnostic criteria and prognostic scales for cardiogenic shock in patients with myocardial infarction as well as analysis of current clinical guidelines. Main results of clinical trials u...